In the rm-ANOVA model with P1-N2 peak-peak asplitudependentendent variable, multivariate test was not significant for the "group" × "blocks" interaction effect (Wilks' Lambda = 0.869, F5,71 = 2.149, p = 0.069) (Table 4).
In the rm-ANOVA model with N1 P1 peak-peak amplitude as dependent variable, multivariate test was significant for the "group" × "blocks" interaction effect (Wilks' Lambda = 0.745, F5,71 = 4.862, p = 0.0007) (Table 3).
In the rm-ANOVA model with N1 P1 peak-peak amplitude as dependent variable, multivariate test was significant for the "group" × "blocks" interaction effect (Wilks' Lambda = 0.711, F10,140 = 2.608, p = 0.006).
In the rm-ANOVA model using VEP N1-P1 peak-peak block amplitude as dependent variable, the multivariate test was significant for the "time" × "blocks" interaction effect (Wilks' Lambda = 0.631, F5,30 = 3.27, p = 0.019).
In the rm-ANOVA model using VEP P1-N2 peak-peak block amplitude as dependent variable, multivariate test was not significant for the "time" × "blocks" interaction effect (Wilks' Lambda = 0.971, F5,30 = 0.180, p = 0.968).
In the rm-ANOVA model using SSEP N20-P25 peak-peak block amplitude as the dependent variable, the multivariate test was significant for the "time" × "blocks" interaction effect (Wilks' Lambda = 0.711, F5,30 = 13.83, p = 0.0007).
Here, a multivariate test is constructed using a term for collapsed rare variants plus terms for each of the common alleles.
As well as including a test of each parameter, a multivariate test is also carried out, testing the effect of each predictor on each set of outcome variables.
The results of the multivariate test are summarized in Table 3. Maternal obesity together with sex concurred with the BMI and β-cell glucose sensitivity to determine the differences in insulin sensitivity and secretion observed in the offspring.
With regard to processes leading to inhibited and/or disinhibited symptoms, multivariate testing was unable to identify different forms of pathogenic care leading to either inhibited, disinhibited or mixed symptoms.
It's worth noting that multivariate testing is only available with a $99/month premium plan.
